KRAS G12D/V/A/C 突变蛋白
  • KRAS G12D/V/A/C 突变蛋白

KRAS G12D/V/A/C 突变蛋白

价格 500
包装 10μg
最小起订量 10μg
发货地 北京
更新日期 2025-08-19

产品详情

中文名称:KRAS G12D/V/A/C 突变蛋白产品类别: 试剂
靶点: N/A种属: N/A
表达系统: N/A
2025-08-19 KRAS G12D/V/A/C 突变蛋白 10μg/500RMB 500 试剂

别名 c Ki ras2 c Kirsten ras protein c-K-ras see all 功能 Ras proteins bind GDP/GTP and possess intrinsic GTPase activity. 疾病相关 Defects in KRAS are a cause of acute myelogenous leukemia (AML) [MIM:601626]. AML is a malignant disease in which hematopoietic precursors are arrested in an early stage of development. Defects in KRAS are a cause of juvenile myelomonocytic leukemia (JMML) [MIM:607785]. JMML is a pediatric myelodysplastic syndrome that constitutes approximately 30% of childhood cases of myelodysplastic syndrome (MDS) and 2% of leukemia. It is characterized by leukocytosis with tissue infiltration and in vitro hypersensitivity of myeloid progenitors to granulocyte-macrophage colony stimulating factor. Defects in KRAS are the cause of Noonan syndrome type 3 (NS3) [MIM:609942]. Noonan syndrome (NS) [MIM:163950] is a disorder characterized by dysmorphic facial features, short stature, hypertelorism, cardiac anomalies, deafness, motor delay, and a bleeding diathesis. It is a genetically heterogeneous and relatively common syndrome, with an estimated incidence of 1 in 1000-2500 live births. Rarely, NS is associated with juvenile myelomonocytic leukemia (JMML). NS3 inheritance is autosomal dominant. Defects in KRAS are a cause of gastric cancer (GASC) [MIM:613659]; also called gastric cancer intestinal or stomach cancer. Gastric cancer is a malignant disease which starts in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. The term gastric cancer or gastric carcinoma refers to adenocarcinoma of the stomach that accounts for most of all gastric malignant tumors. Two main histologic types are recognized, diffuse type and intestinal type carcinomas. Diffuse tumors are poorly differentiated infiltrating lesions, resulting in thickening of the stomach. In contrast, intestinal tumors are usually exophytic, often ulcerating, and associated with intestinal metaplasia of the stomach, most often observed in sporadic disease. Note=Defects in KRAS are a cause of pylocytic astrocytoma (PA). Pylocytic astrocytomas are neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. Defects in KRAS are a cause of cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150]; also known as cardio-facio-cutaneous syndrome. CFC syndrome is characterized by a distinctive facial appearance, heart defects and mental retardation. Heart defects include pulmonic stenosis, atrial septal defects and hypertrophic cardiomyopathy. Some affected individuals present with ectodermal abnormalities such as sparse, friable hair, hyperkeratotic skin lesions and a generalized ichthyosis-like condition. Typical facial features are similar to Noonan syndrome. They include high forehead with bitemporal constriction, hypoplastic supraorbital ridges, downslanting palpebral fissures, a depressed nasal bridge, and posteriorly angulated ears with prominent helices. The inheritance of CFC syndrome is autosomal dominant. Note=KRAS mutations are involved in cancer development.


关键字: KRAS G12D/V/A/C 突变蛋白;

公司简介

佰诺创因(成都)医药科技有限公司利用自身细菌发酵平台、真核细胞培养平台、病毒载体培养平台为客户提供科研试剂。 在原液工艺开发板块,公司展现出强劲的技术实力,搭建起了抗生素发酵技术、细菌发酵重组蛋白、原核质粒、腺病毒、腺相关病毒、流感病毒等工艺和分析技术平台,有力推动客户项目快速实现转化。例如在重组蛋白表达领域,可实现酵母胞内和分泌表达、大肠杆菌胞内可溶表达、大肠杆菌包涵表达和周质空间表达及对应的发酵后处理工艺;质粒方面,产量可达 1g/l 以上,纯度大于 95%;在病毒载体领域,凭借独特的灌流工艺技术平台,实现了病毒的连续化和规模化生产,其中 AAV 产量可达 101?vg/l 。
成立日期 2021-09-14 (5年) 注册资本 1000万
员工人数 10-50人 年营业额 ¥ 1000万-5000万
主营行业 医药原料 经营模式 试剂,定制,服务
  • 佰诺创因(成都)医药科技有限公司
普通会员
  • 公司成立:5年
  • 注册资本:1000万
  • 企业类型:生产制造服务
  • 主营产品:自然科学研究和试验发展;技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广;日用品销售;专用化学产品销售(不含危险化学品)化工产品销售(不含许可类化工产品);生物基材料销售;日用化学产品销售;细胞技术研发和应用
  • 公司地址:四川省成都市温江区永宁街道三医创新中心
询盘

KRAS G12D/V/A/C 突变蛋白相关厂家报价

产品名称 价格   公司名称 报价日期
询价
VIP3年
上海鸿肽生物科技有限公司
2025-06-17
询价
VIP5年
武汉艾美捷科技有限公司
2026-01-14
询价
VIP5年
上海优宁维生物科技股份有限公司
2026-02-12
内容声明:
以上所展示的信息由商家自行提供,内容的真实性、准确性和合法性由发布商家负责。 商家发布价格指该商品的参考价格,并非原价,该价格可能随着市场变化,或是由于您购买数量不同或所选规格不同而发生变化。最终成交价格,请咨询商家,以实际成交价格为准。请意识到互联网交易中的风险是客观存在的
主页 | 企业会员服务 | 广告业务 | 联系我们 | 旧版入口 | 中文MSDS | CAS Index | 常用化学品CAS列表 | 化工产品目录 | 新产品列表 |投诉中心
Copyright © 2008 ChemicalBook 京ICP备07040585号  京公海网安备110108000080号  All rights reserved.